Home Site Map Make Your Home Page Suggestions Enquiry Advertise With Us
Thursday, February 09, 2012  
 
 
News Home
Video News
Press Releases
Features
Events
Special Articles
   
  News Updated on Thursday, February 09, 2012 5:36:07 PM
   Find Us on Facebook    Follow Us
» India » Asia » World » Sports » Business » Sci-Tec » Health » Entertainment » Bollywood » Picture Gallery
 
 India

Potential therapeutic target for curbing inflammation in fat people identified
Washington | November 04, 2009 3:22:50 PM IST
 

 

 

Researchers from University of California, San Diego have identified a potential therapeutic target for curbing inflammation in obese people.

The new evidence would help explain how saturated fatty acids, which soar in those who are obese, can lead the immune system to respond in ways that add up to chronic, low-grade inflammation.

It would open up new avenues for developing treatments to curb that inflammatory state, and the insulin resistance and type 2 diabetes that come with it.

One key is an immune receptor (called Toll-like receptor 4 or Tlr4) at the surface of blood cells, including a particularly "angry" class of macrophages known to pump out toxic molecules and spur inflammation. It now appears that fatty acids may in essence "hijack" those immune cells via Tlr4.

"Tlr4 is out there to sense bacterial products, but one of those looks a lot like fatty acids," said the study's senior author Jerrold Olefsky of the University of California, San Diego.

"They don't know it's not bacteria," Olefsky added.

Scientists had suspected that Tlrs might be the "sensors" linking obesity to inflammation.

In the new study, the researchers show that this interaction is particularly important in the bloodstream. Mice lacking Tlr4 only in blood cells grew obese when they were fed a high-fat diet, but they were largely spared the metabolic consequences of their obesity.

The mice were fat, but metabolically they continued to "look pretty normal," Olefsky added.

"A Tlr4 antagonist - now that's a therapeutic. The jury is still out, but it sure makes sense they could be a new class of insulin sensitizers," Olefsky said.

The researchers said that drugs aimed at Tlr4 have already been developed, and the idea that those drugs may hold promise in fighting insulin resistance and type 2 diabetes is one Olefsky's team is now exploring in detail in the mice.

The study appears in Cell Metabolism, a Cell Press publication. (ANI)

 
  Viewer's Comment
Comments Not Available
 
 More Stories

Phone hacking scandal bill touches $200m for Murdoch\'s News Corp 

Dannii Minogue freaked out by her Madame Tussauds\' wax doll 

E-mails bares US nuke regulatory body\'s chaos on Fukushima crisis 

Class 9 student stabs teacher to death in Chennai 

Moldovan dancer says prove if \'lingerie found in Costa Concordia captain\'s room had her DNA\' 

Bubble-propelled microrockets \'may work in stomach acid\' 

Prince Harry qualifies as Apache helicopter pilot after finishing top in class 

Bernard Tomic\'s girl unhappy with sexually attractive pics in magazine 


Print this Page
Printer Friendly Version
SocialTwist Tell-a-Friend

Search Archives :  



Quick Links - Webindia123.com
Services
Health
Hobbies
Entertainment
Classifieds
Career / Education
UK, USA, Canada
Utilities
E-Booking
India Reference
 
 
 
 
 
Personalities
 
 
 
 
IndianStates
Punjab
 
Rajasthan
 
Sikkim
 
  
Tripura
 
 
 
 
Pondicherry

Copyright 2000-2012 Suni Systems (P) Ltd.
All rights reserved